The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 1, 2026

Conditions
HIV Infected IndividualsHIV
Interventions
BIOLOGICAL

HIV-CAR-T

Intravenous Infusion of CAR-T Cells

All Listed Sponsors
collaborator

Tsinghua University

OTHER

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER